REC-1245
REC-1245-101
Phase 2 small_molecule active
Quick answer
REC-1245 for Unresectable is a Phase 2 program (small_molecule) at RECURSION PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- RECURSION PHARMACEUTICALS, INC.
- Indication
- Unresectable
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active